These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 25825540)

  • 1. Executive functioning of 4 children with hyperphenylalaninemia from childhood to adolescence.
    Sharman R; Sullivan KA; Jones T; Young RM; McGill J
    Pediatrics; 2015 Apr; 135(4):e1072-4. PubMed ID: 25825540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Executive functioning in context: Relevance for treatment and monitoring of phenylketonuria.
    Huijbregts SC; Gassió R; Campistol J
    Mol Genet Metab; 2013; 110 Suppl():S25-30. PubMed ID: 24206933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Executive function in adolescents born <1000 g or <28 weeks: a prospective cohort study.
    Burnett AC; Scratch SE; Lee KJ; Cheong J; Searle K; Hutchinson E; De Luca C; Davey MA; Roberts G; Doyle LW; Anderson PJ;
    Pediatrics; 2015 Apr; 135(4):e826-34. PubMed ID: 25802342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A preliminary investigation of the role of the phenylalanine:tyrosine ratio in children with early and continuously treated phenylketonuria: toward identification of "safe" levels.
    Sharman R; Sullivan K; Young R; McGill J
    Dev Neuropsychol; 2010; 35(1):57-65. PubMed ID: 20390592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Executive functioning in children and adolescents with phenylketonuria.
    VanZutphen K; Packman W; Sporri L; Needham M; Morgan C; Weisiger K; Packman S
    Clin Genet; 2007 Jul; 72(1):13-8. PubMed ID: 17594394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropsychological function in mild hyperphenylalaninemia.
    Smith ML; Saltzman J; Klim P; Hanley WB; Feigenbaum A; Clarke JT
    Am J Ment Retard; 2000 Mar; 105(2):69-80. PubMed ID: 10755172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropsychology of early-treated phenylketonuria: specific executive function deficits.
    Welsh MC; Pennington BF; Ozonoff S; Rouse B; McCabe ER
    Child Dev; 1990 Dec; 61(6):1697-713. PubMed ID: 2083493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical markers associated with executive function in adolescents with early and continuously treated phenylketonuria.
    Sharman R; Sullivan K; Young R; McGill J
    Clin Genet; 2009 Feb; 75(2):169-74. PubMed ID: 19215250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurocognitive functioning in adults with phenylketonuria: results of a long term study.
    Weglage J; Fromm J; van Teeffelen-Heithoff A; Möller HE; Koletzko B; Marquardt T; Rutsch F; Feldmann R
    Mol Genet Metab; 2013; 110 Suppl():S44-8. PubMed ID: 24071437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropsychological assessment among children and adolescents with phenylketonuria and hyperphenylalaninemia and its relationship with plasma phenylalanine levels.
    González García MB; Conde-Guzon P; Alcalde Martín C; Conde-Guzon MJ; Velasco Zúñiga R
    Arch Argent Pediatr; 2017 Jun; 115(3):267-273. PubMed ID: 28504493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-Term Follow-Up of Cognition and Mental Health in Adult Phenylketonuria: A PKU-COBESO Study.
    Jahja R; van Spronsen FJ; de Sonneville LMJ; van der Meere JJ; Bosch AM; Hollak CEM; Rubio-Gozalbo ME; Brouwers MCGJ; Hofstede FC; de Vries MC; Janssen MCH; van der Ploeg AT; Langendonk JG; Huijbregts SCJ
    Behav Genet; 2017 Sep; 47(5):486-497. PubMed ID: 28776207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment and development of executive function (EF) during childhood.
    Anderson P
    Child Neuropsychol; 2002 Jun; 8(2):71-82. PubMed ID: 12638061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability of executive function deficits in girls with ADHD: a prospective longitudinal followup study into adolescence.
    Biederman J; Petty CR; Doyle AE; Spencer T; Henderson CS; Marion B; Fried R; Faraone SV
    Dev Neuropsychol; 2008; 33(1):44-61. PubMed ID: 18443969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropsychological studies on adolescents with phenylketonuria returned to phenylalanine-restricted diets.
    Clarke JT; Gates RD; Hogan SE; Barrett M; MacDonald GW
    Am J Ment Retard; 1987 Nov; 92(3):255-62. PubMed ID: 3426836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Disease course in 20 patients with an early diagnosis of phenylketonuria and hyperphenylalaninemia].
    Schwarz HP; Plüss C; Triaca H; Schütz B; Kaufmann R; Scherz R; Bachmann C; Zuppinger K
    Schweiz Med Wochenschr; 1988 Jan; 118(3):94-9. PubMed ID: 3344414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Challenges and pitfalls in the management of phenylketonuria.
    Feillet F; van Spronsen FJ; MacDonald A; Trefz FK; Demirkol M; Giovannini M; Bélanger-Quintana A; Blau N
    Pediatrics; 2010 Aug; 126(2):333-41. PubMed ID: 20624808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal hyperphenylalaninemia syndrome: neuropsychological evaluation of four subjects during childhood and adolescence.
    Corsello G; Cicero L; Giuffrè M; La Grutta S; Piccione M; Pusateri F; Ciaccio M; Roccella M
    Minerva Pediatr; 2006 Dec; 58(6):557-69. PubMed ID: 17093378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurocognitive and neuroimaging outcome of early treated young adult PKU patients: A longitudinal study.
    Nardecchia F; Manti F; Chiarotti F; Carducci C; Carducci C; Leuzzi V
    Mol Genet Metab; 2015; 115(2-3):84-90. PubMed ID: 25952249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Psychological prospects and scholastic performance of 33 children with early diagnosis of hyperphenylalaninemia].
    Rapoport D; Saudubray JM; Ogier H; Hatt A; Berges J; Depondt E; Charpentier C; Frézal J
    Arch Fr Pediatr; 1983; 40 Suppl 1():273-9. PubMed ID: 6882147
    [No Abstract]   [Full Text] [Related]  

  • 20. Mental health and social functioning in early treated Phenylketonuria: the PKU-COBESO study.
    Jahja R; Huijbregts SC; de Sonneville LM; van der Meere JJ; Bosch AM; Hollak CE; Rubio-Gozalbo ME; Brouwers MC; Hofstede FC; de Vries MC; Janssen MC; van der Ploeg AT; Langendonk JG; van Spronsen FJ
    Mol Genet Metab; 2013; 110 Suppl():S57-61. PubMed ID: 24183792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.